- Shares of Oramed Pharmaceuticals (NASDAQ:ORMP) are down 13% on average volume today as the sell-off continues from its recent parabolic up move that began on December 20.
- Prices rocketed 360% on investors' brief enthusiasm over its insulin pill only to quickly retreat after various observers began scrutinizing the situation.
- Oramed's market cap is $121M.
- Six mutual funds have positions, up from two a year earlier.
Oramed gets roughed up
Recommended For You
More Trending News
About ORMP Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ORMP | - | - |
Oramed Pharmaceuticals Inc. |